NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.940
-0.130 (-6.28%)
At close: Jun 1, 2026, 4:00 PM EDT
1.988
+0.048 (2.48%)
After-hours: Jun 1, 2026, 5:01 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $206.03 million as of June 1, 2026. Its market cap has increased by 10.65% in one year.
Market Cap
206.03M
Enterprise Value
201.07M
1-Year Change
10.65%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $206.03M, an increase of 450.45%. That is a compound annual growth rate of 26.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 219.84M | -50.68% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 231.89M |
| Minerva Neurosciences | 228.75M |
| Camp4 Therapeutics | 227.95M |
| Cybin | 227.66M |
| YD Bio | 226.43M |
| Arcturus Therapeutics Holdings | 225.11M |
| Keros Therapeutics | 222.66M |
| Atrium Therapeutics | 222.37M |